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Abstract

hyperﬂuorescent focus that typically appears
ﬁrst during dye transit, followed by late leakage.
Optical coherence tomography (OCT) localizes
the lesion to the deeper layers of the retina.
The advent of OCT angiography (OCT-A)
enables retinal microvascular ﬂow to be imaged
in the clinical setting without the injection of
intravenous ﬂuorescent dye.

Introduction The characteristics of type
3 neovascularization (NV), also known as
retinal angiomatous proliferation, have been
well described clinically, as well as with
ﬂuorescein angiography (FA), indocyanine
green angiography, and optical coherence
tomography (OCT). OCT angiography (OCTA) is a novel and non-invasive technique for
imaging retinal microvasculature by detecting
changes, with respect to time, in reﬂectivity
related to blood ﬂow.
Method In this case series, we describe two
patients who presented with type 3 NV and
underwent clinical examination and
multimodal imaging, including OCT-A.
Results In the ﬁrst patient, OCT-A
demonstrated ﬂow within two separate lesions
in the same eye, one of which was only
weakly detected by FA. In the second patient,
sequential OCT-A demonstrated a reduction in
intralesional ﬂow following intravitreal therapy.
Conclusions OCT-A may have a role in the
early diagnosis of type 3 NV and in assessing
the response to treatment. Further studies are
needed to determine sensitivity and
speciﬁcity.
Eye (2015) 29, 703–706; doi:10.1038/eye.2015.27;
published online 6 March 2015
Introduction
Type 3 neovascularization (NV), also known as
retinal angiomatous proliferation, is thought to
arise predominantly from the deep capillary
plexus of the retina and grow toward the RPE,
forming anastomoses with type 1 (sub-RPE)
NV.1–4 Fluorescein angiography (FA) reveals, at
the site of the intraretinal vascular lesion, a

Case report 1
An 88-year-old female with a 3-year history
of NV age-related macular degeneration
(NV-AMD) in her right eye presented for
a maintenance injection of intravitreal
bevacizumab. Fundus examination showed a
small new intraretinal hemorrhage in her left
eye. Spectral domain OCT (SD-OCT; OCT
+HRA, Heidelberg Engineering) and FA
conﬁrmed the presence of two separate type 3
NV lesions (Figures 1a and e), the more superior
lesion being only weakly detectable on FA.
The patient also underwent OCT-A (Avanti,
Optovue, Fremont, CA, USA), demonstrating
ﬂow within the active lesions (Figures 1f and g).
Intravitreal ranibizumab was administered to
the left eye to initiate a course of therapy.
Case report 2
A 70-year-old female with a prior history of type
3 NV in her left eye presented for follow up.
Assessment of the previously non-NV right eye
conﬁrmed a new type 3 NV lesion as
documented by color photography, FA/ICG,
and SD-OCT (Figures 2a and d). The patient
underwent swept-source OCT and OCT-A
(Topcon DRI OCT-1, Topcon Corporation,
Tokyo, Japan), following which the volume data
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foveal avascular zone correlating with the location of the
type 3 NV (Figure 2e). The patient began treatment with
intravitreal ranibizumab in the right eye on a monthly
regimen. After two consecutive treatments, SD-OCT
showed a reduction in the retinal thickness with partial
resolution of the retinal cyst and intraretinal hemorrhage.
Repeat OCT-A showed a reduction in the brightness of
the type 3 lesion (Figure 2f); it also revealed a region of
supranormal ﬂow, inferotemporal to the main lesion
(Figure 2f, black arrow).
Discussion

Figure 1 Multimodal imaging of the left eye of patient 1
showing two type 3 NV lesions bordering the foveal avascular
zone. Yellow arrows: high-ﬂow lesion; green arrows: second,
low-ﬂow lesion. (a) Color photograph; (b, c) mid- and latevenous phases of ﬂuorescein angiogram; (d, e) SD-OCT through
high- and low-ﬂow lesions, respectively; (f, g) en face OCT-A
segments of superﬁcial and deep capillary plexus, respectively.

was processed by Topcon using a proprietary
angiography algorithm. The resulting images revealed a
hyperintense ﬂow signal at the inferior border of the

Eye

Type 3 NV may be difﬁcult to diagnose in the early
stages, when it may manifest as intraretinal hyperreﬂective features on OCT, without retinal thickening or
obvious RPE disruption;5 serial FA may be necessary for
early detection.
OCT-A relies on the detection of changes—in
amplitude, phase, or other physical characteristics of the
reﬂected light—that result from the interaction with the
components of the ﬂowing blood.6 These are rendered as
two-dimensional en face maps in which the pixel
brightness represents blood ﬂow.7 The relative absence of
stationary or time-static structures from OCT-A maps
distinguishes these images from those rendered by
conventional en face OCT.
Our ﬁrst patient had two foci of type 3 NV. The lesion
at the superior border of the foveal avascular zone was
seen on SD-OCT but was only detected weakly by FA.
OCT-A demonstrated both the lesions, one with a
stronger ﬂow signal than the other (the inferior, brighter
lesion saturating the detection capabilities of the device).
En face segmentation enhanced the sensitivity of OCT-A
to detect these lesions, by excluding the ﬂow signals from
the inner retinal capillaries. Segmentation also localized
the lesions to the deep capillary plexus, consistent with
type 3 NV.
In the second patient, OCT-A demonstrated a single
type 3 NV lesion in the deep capillary plexus,
communicating with a sub-RPE component. Sequential
OCT-A suggested a reduction in the intralesional ﬂow as
a result of the treatment with 2 anti-VEGF injections as
represented by a reduction in brightness. It also revealed
a complex of ectatic capillaries, inferior to the main lesion,
with supranormal ﬂow, not detectable by FA or ICGA in
our patient. Telangiectasis adjacent to type 3 NV has
recently been described as an early feature of type 3 NV.8
The technology to perform OCT-A in the clinical setting
is now commercially available. OCT-A detects, and may
quantify, ﬂow in early or partially treated type 3 NV
lesions, and has the potential to increase our
understanding of the pathogenesis. To the best of our
knowledge, this is the ﬁrst published report of OCT-A of
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Figure 2 Multimodal imaging of the right eye of patient 2 showing a type 3 NV lesion (yellow arrow) at the inferior border of the
foveal avascular zone, and accompanying intraretinal hemorrhage that is adjacent and superior (red arrow). (a) Color photograph;
(b) ﬂuorescein angiogram; (c) indocyanine green angiogram; (d) SD-OCT showing a hyper-reﬂective intraretinal lesion communicating
with a localized pigment epithelial detachment at its outer aspect and an adjacent hemorrhage within a cystic space at its inner aspect;
(e) baseline OCT angiogram; (f) OCT angiogram after two intravitreal treatments. Supranormal ﬂow is seen in a region of the capillary
plexus inferior to the type 3 lesion (black arrow).
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type 3 NV. Larger studies are needed to determine the
sensitivity and speciﬁcity of OCT-A in the early diagnosis
of type 3 NV, and its reliability in determining lesion
activity, through quantiﬁcation of microvascular ﬂow.
Summary
What was known before
K Type 3 NV is well described on the basis of clinical
ﬁndings and multimodal imaging including FA and crosssectional OCT.
What this study adds
K Our cases show that OCT-A is capable of demonstrating
ﬂow in early type 3 NV (that is only weakly detectable on
FA), and that OCT-A is capable of quantifying a reduction
in ﬂow following intravitreal therapy.
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